Figure legends:
Figure 1. ZnO nanoparticles characetrixation. FESEM image (A) and XRD pattern (B) of ZnO nanoparticles.
Figure 2. Chitosan hydrogel characterization. FTIR spectrums of chitosan polymer (A) and chitoan hudrogel (B). FESEM image of chitosan hydrogel (C).
Figure 3. Swelling ratio of different hydrogel formulations in PBS and citarte buffer mediums.
Figure 4. A) Drug release profiles of different hydrogel formulations at pH 7.4 in the presence and absence of ZnO nanoparticles. B) Drug release profiles of hydrogel forulation with 2 mg genipin and ZnO nanoparticles at different pHs 7.4 and 5.8. C) The release profile of ZnO nanoparticles from the different hydrogel formulations in two different pH 7.4 and pH 5.8.
Figure 5 . Inhibition zone diameters (mm) of S. aureus (green) and P.aeruginosa(blue) grown in the presence of vancomycin, chitosan hydrogel (CH), chitosan hydrogel contained ZnO NPs (CNH) and chitosan hydrogel loaded by vancomycin and ZnO NPs (CNH loaded vancomycin). Data are represented as mean ± SD (n=3).
** Denotes significant differences with p<0.0002 and
*** Denotes significant differences with p<0.0001.
Figure 6 . Bacterial number of S. aureus (green) andP.aeruginosa (blue) after treatment with chitosan hydrogel (CH), chitosan hydrogel contained ZnO NPs (CNH) and chitosan hydrogel loaded by vancomycin and ZnO NPs (CNH loaded vancomycin). Data are represented as mean ± SD (n=3)
* Denotes significant differences with p<0.05 and
*** Denotes significant differences with p<0.0001